181 related articles for article (PubMed ID: 28756877)
41. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity.
Jun EA; Lim KM; Kim K; Bae ON; Noh JY; Chung KH; Chung JH
Nanotoxicology; 2011 Jun; 5(2):157-67. PubMed ID: 20822370
[TBL] [Abstract][Full Text] [Related]
42. Activation and shedding of platelet glycoprotein IIb/IIIa under non-physiological shear stress.
Chen Z; Mondal NK; Ding J; Koenig SC; Slaughter MS; Griffith BP; Wu ZJ
Mol Cell Biochem; 2015 Nov; 409(1-2):93-101. PubMed ID: 26160282
[TBL] [Abstract][Full Text] [Related]
43. Palladin is involved in platelet activation and arterial thrombosis.
Chen X; Fan X; Tan J; Shi P; Wang X; Wang J; Kuang Y; Fei J; Liu J; Dang S; Wang Z
Thromb Res; 2017 Jan; 149():1-8. PubMed ID: 27865965
[TBL] [Abstract][Full Text] [Related]
44. The procoagulant effect of thrombin on fibrin(ogen)-bound platelets.
Sanders MW; Nieuwenhuys CM; Feijge MA; Rook M; Béguin S; Heemskerk JW
Haemostasis; 1998; 28(6):289-300. PubMed ID: 10461011
[TBL] [Abstract][Full Text] [Related]
45. OC-08 - Multiple functional defects in platelets from thrombocytopenic cancer patients undergoing chemotherapy.
Baaten CC; Moenen FC; Henskens YM; Swieringa F; Wetzels R; van Oerle R; Ten Cate H; Beckers EA; Heemskerk JW; van der Meijden PE
Thromb Res; 2016 Apr; 140 Suppl 1():S171. PubMed ID: 27161680
[TBL] [Abstract][Full Text] [Related]
46. The effects of arterial flow on platelet activation, thrombus growth, and stabilization.
Cosemans JM; Angelillo-Scherrer A; Mattheij NJ; Heemskerk JW
Cardiovasc Res; 2013 Jul; 99(2):342-52. PubMed ID: 23667186
[TBL] [Abstract][Full Text] [Related]
47. Minding the gaps to promote thrombus growth and stability.
Brass LF; Zhu L; Stalker TJ
J Clin Invest; 2005 Dec; 115(12):3385-92. PubMed ID: 16322784
[TBL] [Abstract][Full Text] [Related]
48. The platelet-cancer loop.
Goubran HA; Burnouf T; Radosevic M; El-Ekiaby M
Eur J Intern Med; 2013 Jul; 24(5):393-400. PubMed ID: 23433737
[TBL] [Abstract][Full Text] [Related]
49. The evaluation of platelet indices and markers of inflammation, coagulation and disease progression in treatment-naïve, asymptomatic HIV-infected individuals.
Nkambule BB; Davison GM; Ipp H
Int J Lab Hematol; 2015 Aug; 37(4):450-8. PubMed ID: 25401263
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of complement component C5 prevents clotting in an ex vivo model of xenogeneic activation of coagulation.
Rataj D; Werwitzke S; Haarmeijer B; Winkler M; Ramackers W; Petersen B; Niemann H; Wünsch A; Bähr A; Klymiuk N; Wolf E; Abicht JM; Ayares D; Tiede A
Xenotransplantation; 2016 Mar; 23(2):117-27. PubMed ID: 26773447
[TBL] [Abstract][Full Text] [Related]
51. Novel methodology for assessment of prophylactic platelet transfusion therapy by measuring increased thrombus formation and thrombin generation.
Cauwenberghs S; Feijge MA; Theunissen E; Heemskerk JW; van Pampus EC; Curvers J
Br J Haematol; 2007 Feb; 136(3):480-90. PubMed ID: 17176266
[TBL] [Abstract][Full Text] [Related]
52. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.
Vandendries ER; Hamilton JR; Coughlin SR; Furie B; Furie BC
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):288-92. PubMed ID: 17190826
[TBL] [Abstract][Full Text] [Related]
53. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
Lee H; Sturgeon SA; Jackson SP; Hamilton JR
Thromb Haemost; 2012 Feb; 107(2):328-37. PubMed ID: 22187047
[TBL] [Abstract][Full Text] [Related]
54. New targets for antithrombotic drugs.
Thiagarajan P
Am J Cardiovasc Drugs; 2002; 2(4):227-35. PubMed ID: 14727968
[TBL] [Abstract][Full Text] [Related]
55. Prolonged expression of procoagulant activity of human platelets degranulated by thrombin.
Kinlough-Rathbone RL; Perry DW
Thromb Haemost; 1995 Sep; 74(3):958-61. PubMed ID: 8571329
[TBL] [Abstract][Full Text] [Related]
56. Platelet microparticle: a sensitive physiological "fine tuning" balancing factor in health and disease.
Goubran HA; Burnouf T; Stakiw J; Seghatchian J
Transfus Apher Sci; 2015 Feb; 52(1):12-8. PubMed ID: 25599988
[TBL] [Abstract][Full Text] [Related]
57. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
Morel O; Morel N; Freyssinet JM; Toti F
Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
[TBL] [Abstract][Full Text] [Related]
58. Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes.
Martín M; de Paz R; Jiménez-Yuste V; Fernández Bello I; García Arias Salgado E; Alvarez MT; Butta NV
Thromb Haemost; 2013 May; 109(5):909-19. PubMed ID: 23407717
[TBL] [Abstract][Full Text] [Related]
59. Arsenite-enhanced procoagulant activity through phosphatidylserine exposure in platelets.
Bae ON; Lim KM; Noh JY; Chung SM; Kim H; Lee CR; Park JD; Chung JH
Chem Res Toxicol; 2007 Dec; 20(12):1760-8. PubMed ID: 17915961
[TBL] [Abstract][Full Text] [Related]
60. Absence of platelet-dependent fibrin formation in a patient with Scott syndrome.
Wielders SJ; Broers J; ten Cate H; Collins PW; Bevers EM; Lindhout T
Thromb Haemost; 2009 Jul; 102(1):76-82. PubMed ID: 19572071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
